An open-label extension study to assess the long-term safety and clinical benefit of etanercept in pediatric patients with extended oligo, enthesitis related, and psoriatic JIA: 6-year data from the clipper studies

Ivan Foeldvari; Tamas Constantin; Jelena Vojinovic; Gerd Horneff; Joke Dehoorne; Gordana Susic; Katarzyna Kobusinska; Violeta Panaviene; Zbigniew Zuber; Valda Stanevica; Vyacheslav G. Chasnyk; Ronald D. Pedersen; Jack F. Bukowski; Tina Hinnershitz; Bonnie Vlahos; Alberto Martini; Nicolino Ruperto

An open-label extension study to assess the long-term safety and clinical benefit of etanercept in pediatric patients with extended oligo, enthesitis related, and psoriatic JIA: 6-year data from the clipper studies

Ivan Foeldvari, Tamas Constantin, Jelena Vojinovic, Gerd Horneff, Joke Dehoorne, Gordana Susic, Katarzyna Kobusinska, Violeta Panaviene, Zbigniew Zuber, Valda Stanevica, Vyacheslav G. Chasnyk, Ronald D. Pedersen, Jack F. Bukowski, Tina Hinnershitz, Bonnie Vlahos, Alberto Martini, Nicolino Ruperto

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	P71
Pages (from-to)	49
Journal	Pediatric Rheumatology
Volume	15
Issue number	Suppl.2
Publication status	Published - 2017
Externally published	Yes
Event	24th European Paediatric Rheumatology Congress - Athens, Greece Duration: 14 Sept 2017 → 17 Sept 2017 Conference number: 24 https://www.pres.eu/pres2017/

Field of Science*

3.2 Clinical medicine

Publication Type*

3.4. Other publications in conference proceedings (including local)

Cite this

Foeldvari, I., Constantin, T., Vojinovic, J., Horneff, G., Dehoorne, J., Susic, G., Kobusinska, K., Panaviene, V., Zuber, Z., Stanevica, V., Chasnyk, V. G., Pedersen, R. D., Bukowski, J. F., Hinnershitz, T., Vlahos, B., Martini, A., & Ruperto, N. (2017). An open-label extension study to assess the long-term safety and clinical benefit of etanercept in pediatric patients with extended oligo, enthesitis related, and psoriatic JIA: 6-year data from the clipper studies. Pediatric Rheumatology, 15(Suppl.2), 49. Article P71.

@article{f2cc47e4069b4c46add7fa7981131fdd,

title = "An open-label extension study to assess the long-term safety and clinical benefit of etanercept in pediatric patients with extended oligo, enthesitis related, and psoriatic JIA: 6-year data from the clipper studies",

author = "Ivan Foeldvari and Tamas Constantin and Jelena Vojinovic and Gerd Horneff and Joke Dehoorne and Gordana Susic and Katarzyna Kobusinska and Violeta Panaviene and Zbigniew Zuber and Valda Stanevica and Chasnyk, {Vyacheslav G.} and Pedersen, {Ronald D.} and Bukowski, {Jack F.} and Tina Hinnershitz and Bonnie Vlahos and Alberto Martini and Nicolino Ruperto",

year = "2017",

language = "English",

volume = "15",

pages = "49",

journal = "Pediatric Rheumatology",

issn = "1546-0096",

publisher = "BioMed Central Ltd.",

number = "Suppl.2",

note = "24th European Paediatric Rheumatology Congress, PReS 2017 ; Conference date: 14-09-2017 Through 17-09-2017",

url = "https://www.pres.eu/pres2017/",

}

Foeldvari, I, Constantin, T, Vojinovic, J, Horneff, G, Dehoorne, J, Susic, G, Kobusinska, K, Panaviene, V, Zuber, Z, Stanevica, V, Chasnyk, VG, Pedersen, RD, Bukowski, JF, Hinnershitz, T, Vlahos, B, Martini, A & Ruperto, N 2017, 'An open-label extension study to assess the long-term safety and clinical benefit of etanercept in pediatric patients with extended oligo, enthesitis related, and psoriatic JIA: 6-year data from the clipper studies', Pediatric Rheumatology, vol. 15, no. Suppl.2, P71, pp. 49.

An open-label extension study to assess the long-term safety and clinical benefit of etanercept in pediatric patients with extended oligo, enthesitis related, and psoriatic JIA: 6-year data from the clipper studies. / Foeldvari, Ivan; Constantin, Tamas; Vojinovic, Jelena et al.
In: Pediatric Rheumatology, Vol. 15, No. Suppl.2, P71, 2017, p. 49.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - An open-label extension study to assess the long-term safety and clinical benefit of etanercept in pediatric patients with extended oligo, enthesitis related, and psoriatic JIA

T2 - 24th European Paediatric Rheumatology Congress

AU - Foeldvari, Ivan

AU - Constantin, Tamas

AU - Vojinovic, Jelena

AU - Horneff, Gerd

AU - Dehoorne, Joke

AU - Susic, Gordana

AU - Kobusinska, Katarzyna

AU - Panaviene, Violeta

AU - Zuber, Zbigniew

AU - Stanevica, Valda

AU - Chasnyk, Vyacheslav G.

AU - Pedersen, Ronald D.

AU - Bukowski, Jack F.

AU - Hinnershitz, Tina

AU - Vlahos, Bonnie

AU - Martini, Alberto

AU - Ruperto, Nicolino

N1 - Conference code: 24

PY - 2017

Y1 - 2017

M3 - Meeting Abstract

SN - 1546-0096

VL - 15

SP - 49

JO - Pediatric Rheumatology

JF - Pediatric Rheumatology

IS - Suppl.2

M1 - P71

Y2 - 14 September 2017 through 17 September 2017

ER -